Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Shenzhen Sungening Bio-Medical Co. Ltd. is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit. This concentrated focus indicates a specific technical path for the company's current prosecution. By operating within 1 art unit, the company maintains a narrow procedural footprint at the patent office. This structure allows the legal team to focus their resources on the requirements of a specific technical group within the Biotechnology & Pharmaceuticals field.
The busiest examiner, RAO, PADMAJA S, is responsible for 1 pending office action. This 1 action is the only pending office action in the portfolio. With 1 examiner handling the 1 active action, the company's prosecution is currently centralized under this individual. For the practitioner, understanding the specific preferences of RAO, PADMAJA S is the primary factor in the current prosecution strategy. The outcome of the 1 pending office action will be determined by the review and feedback provided by this identified examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAO, PADMAJA S | 1 | 70.7% | +36.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18254465 | A SERIES OF PYRROLE DERIVATIVES AND THEIR PREPARATION METHOD AND THERAPEUTIC USE | RAO, PADMAJA S | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18254465 | A SERIES OF PYRROLE DERIVATIVES AND THEIR PREPARATION METHOD AND THERAPEUTIC USE | RAO, PADMAJA S | 1627 | §112 | Final Rejection | — | Pending | Nov 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShenzhen Sungening Bio-Medical Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Padmaja S Rao has the most, with 1 of Shenzhen Sungening Bio-Medical Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
